How to prolong the effects of combination therapy for HIV

Karpas, 1990, Origin and spread of AIDS, Nature, 384, 578, 10.1038/348578a0 Sabin, 1992, Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portalentary, Proc. Natl. Acad. Sci. U. S. A., 89, 8852, 10.1073/pnas.89.18.8852 Malik, 1988, Molecular cloning and complete nucleotide sequence of an adult T-cell leukaemia virus type I (ATLV/HTLV) isolated of Caribbean origin: relationship to other members of the ATLV/HTLV-1 subgroup, J. Gen. Virol., 69, 1695, 10.1099/0022-1317-69-7-1695 Mir, 1988, Zidovudine and bone marrow, Lancet, ii, 1195, 10.1016/S0140-6736(88)90262-0 Wei, 1995, Viral dynamics in human immunodeficiency virus type 1 infection, Nature, 373, 117, 10.1038/373117a0 Hamilton, 1992, A controlled trial of early viruses late treatment with zidovudine in symptomatic human immunodeficiency virus infection, New Engl. J. Med., 326, 437, 10.1056/NEJM199202133260703 Derbyshire, J. (1995) Extended follow-up of four European/Australian randomised trials of Zidovudim in symptomatic HIV infection, Proceedings of the Fifth European Conference on Clinical Aspects and Treatment of HIV Infection. Copenhagen, Denmark, 26–29 September Scott, 1996, The delta trial, Lancet, 348, 1238, 10.1016/S0140-6736(05)65507-9 Cohen, 1997, The daunting challenge of keeping HIV suppressed, Science, 277, 32, 10.1126/science.277.5322.32 Wong, 1997, Recovery of replication-competent HIV despite prolonged suppression of plasma viraemia, Science, 278, 1291, 10.1126/science.278.5341.1291 Finzi, 1997, Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy, Science, 278, 1291, 10.1126/science.278.5341.1295 Ho, 1995, Time to hit HIV, early and hard, New Engl. J. Med., 333, 450, 10.1056/NEJM199508173330710 Karpas, 1985, Lytic infection by British AIDS virus and the development of rapid cell test for antiviral antibodies, Lancet, ii, 695, 10.1016/S0140-6736(85)92934-4 Karpas, 1988, Effect of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome, Proc. Natl. Acad. Sci. U. S. A., 87, 9234, 10.1073/pnas.85.23.9234 Ho, 1987, Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins, J. Virol., 61, 2024, 10.1128/JVI.61.6.2024-2028.1987 Cao, 1995, Virologic and immunologic characterization of long term survivors of human immunodeficiency virus type 1 infection, New Engl. J. Med., 332, 201, 10.1056/NEJM199501263320401 Pantalio, 1995, Studies in subjects with long-term non progressive human immunodeficiency virus infection, New Engl. J. Med., 332, 209, 10.1056/NEJM199501263320402 Rossi, 1989, Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with uninfected status of children born to seropositive mothers, Proc. Natl. Acad. Sci. U. S. A., 86, 8055, 10.1073/pnas.86.20.8055 Devash, 1990, Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain, Proc. Natl. Acad. Sci. U. S. A., 87, 3445, 10.1073/pnas.87.9.3445 Scarlatti, 1993, Mother to child transmission of human immunodeficiency type 1: correlation with neutralizing antibodies against primary isolates, J. Infect. Dis., 168, 207, 10.1093/infdis/168.1.207 Lambert, 1997, Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns, J. Infect. Dis., 175, 283, 10.1093/infdis/175.2.283 Karpas, 1990, Polymerase chain reaction evidence for human immunodeficiency virus-1 neutralization by passive immunization in patients with AIDS and AIDS-related complex, Proc. Natl. Acad. Sci. U. S. A., 87, 1195, 10.1073/pnas.87.19.7613 Jackson, 1988, Passive immunoneutralization of human immunodeficiency virus in patients with AIDS, Lancet, 2, 647, 10.1016/S0140-6736(88)90468-0 Levy, 1994, Passive hyperimmune therapy in the treatment of AIDS: results of a multicentre double blind controlled trial, Blood, 84, 2130, 10.1182/blood.V84.7.2130.2130 Vittecoq, 1995, Passive immunotherapy in AIDS. A double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies versus transfusions of seronegative plasma, Proc. Natl. Acad. Sci. U. S. A., 92, 1195, 10.1073/pnas.92.4.1195 Jacobson, 1993, Passive immunotherapy in treatment of advanced HIV infection, J. Infect. Dis., 168, 288, 10.1093/infdis/168.2.298 Bainbridge, 1997, Can repeated plasma donation by asymptomatic HIV-infected indiiduals delay the onset of AIDS?, Philos. Trans. R. Soc. London Ser. B, 352, 763, 10.1098/rstb.1997.0060 Cummins, 1991, Preparation and characterisation of an intravenous solution IgG from HIV seropositive donors, Blood, 77, 1111, 10.1182/blood.V77.5.1111.1111 Blick, 1998, Passive immunotherapy in advanced HIV infection and therapeutic plasmapheresis in asymptomatic HIV-positive individuals: a four-year clinical experience, Biotherapy, 11, 7, 10.1023/A:1007920613598 Psallidopoulos, 1989, Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals, J. Virol., 63, 4626, 10.1128/JVI.63.11.4626-4631.1989 Matsuyama, 1991, Cytokines and HIV infection: is AIDS a tumor necrosis factor disease?, AIDS, 5, 1405, 10.1097/00002030-199112000-00001 Phillips, 1989, Cyclosporin-induced deterioration in patients with AIDS, Can. Med. Assoc. J., 140, 1456 Schwartz, 1993, The effect of cyclosporin on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation: date of four cases and a review of the literature, Transplantation, 55, 95, 10.1097/00007890-199301000-00019 Karpas, 1992, Inhibition of HIV and growth of infected T-cells by the immunosuppression drugs cyclosporin A and FK506, Proc. Natl. Acad. Sci. U. S. A., 89, 8351, 10.1073/pnas.89.17.8351 Goldfeld, 1992, Transcription of the tumour necrosis factor α gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells, Proc. Natl. Acad. Sci. U. S. A., 89, 12198, 10.1073/pnas.89.24.12198 Cohen, 1998, Failure isn't what it used to be but neither is success, Science, 279, 1133, 10.1126/science.279.5354.1133